Impact of Therapeutic Education, Being Set up Under the Authorized Program for Diabetics Patients in Hospital (ImETh)
Impact Des Actions d'éducation thérapeutique Mises en Place Dans le Cadre d'un Programme autorisé auprès de Patients diabétiques hospitalisés
To Assess the impact of therapeutic education on:
- the occurrence of long term diabetes complications .
- balance of his diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
evaluation of the benefits of therapeutic education by:
- glycated hemoglobin assay
- telephone monitoring
- quiz
- monitoring of adverse event related to diabete
Study Type
Study Type
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria: Patients
- diabetic
- hospitalized in Léon Berard
- with telephone line
- written consent given
- belong to a social security system
Exclusion Criteria:
- no diabetics
- patient having alredy completing a therapeutic education program
- minor patient (<18 years)
- pregnant woman
- without telephone line
- no belong to a social security system
- patient alredy inclued on clinical study.
- patient tutelage or under curatorship
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Therapeutic Education + Documentation
diabetic patient hospitalized patient particpating in therapeutic education program
|
participation in a therapeutic education program on diabetes
|
|
No Therapeutic Education No Documents
diabetic patient hospitalized patient without therapeutic education program no documentation submitted
|
|
|
Documentation, No Therapeutic Education
diabetic patient hospitalized patient without therapeutic education program documentation submitted
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
glycated hemoglobin measure
Time Frame: 3 months
|
blood sample
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hopitalization
Time Frame: 3 months
|
hospitlization related to diabetes
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Alkassoum Sapha, Medecin, medecin
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Protocole#5-Version1.0
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.